Maja Zukic Bonacorsi

Maja Zukic Bonacorsi has a diverse work experience spanning multiple industries. Maja currently works as a Principal Scientist at Tallac Therapeutics, where they specialize in antibody discovery and preclinical research and development of biologics. Prior to this role, they worked as a Senior Scientist at Tallac Therapeutics, where they were responsible for antibody discovery and hybridoma lead.

Before joining Tallac Therapeutics, Maja worked at Immutics as a Senior Scientist from 2019 to 2020. Their responsibilities in this role are not provided.

Maja also has previous experience at Pfizer, where they held the positions of Scientist and Senior Associate Scientist from 2011 to 2019. Their specific roles and responsibilities are not mentioned.

Prior to Pfizer, Maja worked as a Research Associate at Escape Therapeutics, specializing in stem cell research as part of a CIRM Fellowship.

Maja also gained experience as a Research Associate at SRI International, where they studied immunological diseases, investigated small molecules for the treatment/cure of IBD, and developed immunological, molecular, and cell-based assays under GLP and non-GLP regulations.

Before their career in the scientific field, Maja worked as a Specialized Trainer at Club One, where they designed and implemented nutritional and exercise programs for clients of all fitness levels, as well as supervised group programs for lifestyle fitness and weight loss.

Their earliest work experience was as a Microbiology Intern at the California Department of Public Health.

Overall, Maja Zukic Bonacorsi has developed expertise in various scientific areas, including antibody discovery, biologics research and development, stem cell research, and immunological diseases.

Maja Zukic Bonacorsi completed their Bachelor of Science degree in Biology and Physiology at San Francisco State University from 2004 to 2007. Following this, they pursued a Masters of Arts in Stem Cell Biology at San Jose State University, which they completed from 2009 to 2011.